Kaspersky alerts on increasing pharmaceuticals cyber-crimes

Global cybersecurity company Kaspersky reveals an alarming trend observed in the pharmaceutical industry – a year-...

September 10, 2019 | Tuesday | News
10 years journey of Inrebic

Celgene Corporation’s INREBIC (fedratinib) became the first drug to be approved by the U S Food and Drug Administr...

September 10, 2019 | Tuesday | Analysis
Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound

Boehringer Ingelheim and Lupin Limited (Lupin) has announced a licensing, development and commercialization agreement fo...

September 9, 2019 | Monday | News
Schrödinger, AstraZeneca join hands to accelerate drug dicovery

Schrödinger, scientific leader in developing state-of-the-art chemical simulation software, has announced...

September 5, 2019 | Thursday | News
Mundipharma, Cidara ink $568M deal for antifungal treatment

Cidara Therapeutics, Inc. and Mundipharma have announced that they have entered into a strategic partnership to develop ...

September 4, 2019 | Wednesday | News
Velabs Therapeutics partners with alytas for obesity treatment

Velabs Therapeutics GmbH (Velabs), a biotech company focused on the rapid screening of functional therapeutic antibodies...

September 3, 2019 | Tuesday | News
Abbott unveils new detection platform in Brazil

Abbott, a global health care company, launches in Brazil its ID NOW ™point of care molecular platfo...

September 2, 2019 | Monday | News
SC Johnson Spatial repellent innovation provides potential solution for malaria

The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting...

August 30, 2019 | Friday | News
BioCity invests in early-stage precision medicine biotech

BioCity, the pioneering life science incubator and business collective, on 29 August 2019, announced an investment in pr...

August 29, 2019 | Thursday | News
Crozet partners with PHV to develop Nipah virus vaccine

Crozet BioPharma has announced a $10.8 million total value partnering agreement with Public Health Vaccines (P...

August 28, 2019 | Wednesday | News
Harbour BioMed, PPD partner for oncology and immunology

Harbour BioMed (HBM), a global clinical-stage biopharmaceutical company, and Pharmaceutical Product Development, LL...

August 28, 2019 | Wednesday | News
FDA fast tracks AstraZeneca's FARXIGA

AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the deve...

August 28, 2019 | Wednesday | News
Global Neurorehabilitation devices market to be worth $3.2B by 2024

The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising pr...

August 28, 2019 | Wednesday | News
FDA approves new add-on drug to treat Parkinson's disease

The U.S. Food and Drug Administration, on 27 August 2019, approved Nourianz (istradefylline) tablets as an add-on treatm...

August 28, 2019 | Wednesday | News
KPMG, Thermo Fisher to work on gene interaction with medicines

KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with ph...

August 28, 2019 | Wednesday | News
Studies shows critically ill patients use Masimo ORi to reduce hyperoxia

Masimo, on 27 August 2019, announced the latest publication of a report on 150 randomized controlled trials of ICU ...

August 27, 2019 | Tuesday | News
Agilent Completes Acquisition of BioTek Instruments

Agilent Technologies has announced it has completed the acquisition of BioTek Instruments, a global leader in the design...

August 27, 2019 | Tuesday | News
GE's Drawbridge Health Receives FDA nod for blood testing system

Drawbridge Health, Founded in 2015 by GE Ventures and GE Healthcare, Drawbridge Health is a healthcare technology c...

August 27, 2019 | Tuesday | News